My Viva joins CMS ACCESS Model for chronic care management

My Viva Inc. has been accepted into the CMS ACCESS Model, a voluntary payment program that rewards better health outcomes over visit volume. The company will use its lifestyle medicine platform to support care for chronic conditions between clinic appointments.

Why it matters: - The CMS ACCESS Model pushes reimbursement toward measurable outcomes instead of the number of visits or procedures. - My Viva’s acceptance gives the company a path to support chronic care programs that extend beyond the clinic. - The model is aimed at technology-enabled care that helps patients manage day-to-day behaviors linked to outcomes.

What happened: - My Viva Inc. said Sept. 15, 2026, that it was named among the accepted applicants for the Centers for Medicare & Medicaid Services Advancing Chronic Care with Effective, Scalable Solutions, or ACCESS, Model. - The company said it will support the eCKM and CKM tracks through My Viva Plan®, its lifestyle medicine platform. - My Viva described the platform as a tool that extends care between clinic visits.

The details: - The ACCESS Model is a voluntary payment model. - Participating organizations are compensated based on their ability to show improved patient outcomes. - My Viva Plan® is certified by the American College of Lifestyle Medicine. - The platform turns clinical goals into personalized daily actions. - At the start of a patient’s journey, clinicians get a baseline view that includes biometrics, nutrition patterns, physical activity, sleep, stress management, and other health behaviors. - The platform then creates a personalized lifestyle medicine plan aligned with the patient’s diagnosis, health goals, and clinical measures. - Patients receive ongoing guidance and engagement during the program. - Clinicians receive updates on changes in lifestyle behaviors, health measures, and adherence to care recommendations. - My Viva said 88% of participants have maintained healthy habits over the long term. - The company said its approach helps patients build sustainable habits while giving care teams more visibility into factors affecting outcomes.

Between the lines: - The announcement fits a broader shift in chronic care toward integrated management of cardiovascular disease, kidney disease, diabetes, and obesity. - My Viva is positioning its platform around the gap between appointments, where self-management and behavior change often determine results. - The company is also targeting CKM syndrome, a framework that links cardiovascular, kidney, and metabolic health. - A recent American Heart Association survey found that about 9 in 10 U.S. adults have not heard of CKM syndrome, even though the condition affects 90% of U.S. adults. - That awareness gap suggests room for tools that make complex chronic disease management easier to understand and track.

What’s next: - My Viva said the ACCESS Model will create new opportunities for technology-enabled chronic disease management. - The company is now positioned to help healthcare organizations engage patients, track outcomes, and deliver personalized lifestyle medicine at scale. - My Viva said it will continue building and refining My Viva Plan through its Living Lab, where healthcare professionals work directly with patients.

The bottom line: - My Viva’s ACCESS Model acceptance gives the company a federal-payment foothold for its technology-driven chronic care platform, with a focus on outcomes, patient self-management, and care between visits.